Protective Effects of Vitamin E against Oxidative Damage Induced by Aβ1–40Cu(II) Complexes
Xueling DAI
College of Life Science, Capital Normal University, Beijing 100037, China
Search for more papers by this authorYaxuan SUN
College of Applied Sciences and Humanities of Beijing Union University, Beijing 100083, China
Search for more papers by this authorCorresponding Author
Zhaofeng JIANG
College of Applied Sciences and Humanities of Beijing Union University, Beijing 100083, China
*Corresponding author: Tel, 86-10-64900138; Fax, 86-10-64900143; E-mail, [email protected]Search for more papers by this authorXueling DAI
College of Life Science, Capital Normal University, Beijing 100037, China
Search for more papers by this authorYaxuan SUN
College of Applied Sciences and Humanities of Beijing Union University, Beijing 100083, China
Search for more papers by this authorCorresponding Author
Zhaofeng JIANG
College of Applied Sciences and Humanities of Beijing Union University, Beijing 100083, China
*Corresponding author: Tel, 86-10-64900138; Fax, 86-10-64900143; E-mail, [email protected]Search for more papers by this authorThis work was supported by the grants from the Technology Development Program of the Beijing Education Committee and the Key Program of the Beijing Natural Science Foundation (No. KZ200311417015)
Abstract
β-amyloid peptide (A(3) is considered to be responsible for the formation of senile plaques, which is the hallmark of Alzheimer's disease (AD). Oxidative stress, manifested by protein oxidation and lipid peroxidation, among other alterations, is a characteristic of AD brain. A growing body of evidence has been presented in support of Ap1–40 forming an oligomeric complex that binds copper at a CuZn superoxide dismutase-like binding site. Aβ1–40Cu(II) complexes generate neurotoxic hydrogen peroxide (H2O2) from O2 via Cu2+ reduction, though the precise reaction mechanism is unclear. The toxicity of Ap1–40 or the Ap1–40Cu(II) complexes to cultured primary cortical neurons was partially attenuated when (+)-α-tocopherol (vitamin E) as free radical antioxidant was added at a concentration of 100 μM. The data derived from lactate dehydrogenase (LDH) release and the formation of H2O2 confirmed the results from the MTT assay. These findings indicate that copper binding to Aβ1–40 can give rise to greater production of H2O2, which leads to a breakdown in the integrity of the plasma membrane and subsequent neuronal death. Groups treated with vitamin E exhibited much slighter damage, suggesting that vitamin E plays a key role in protecting neuronal cells from dysfunction or death.
Edited by Liqin ZHAO
References
- 1 Hodges JR. Alzheimer's centennial legacy: Origins, landmarks and the current status of knowledge concerning cognitive aspects. Brain 2006, 129: 2811–2822
- 2 Selkoe DJ. Translating cell biology into therapeutic advances in Alzheimer's disease. Nature 1999, 399(Suppl): A23–A31
- 3 Goedert M, Spillantini MG. A century of Alzheimer's disease. Science 2006, 314: 777–781
- 4 Huang X, Moir RD, Tanzi RE, Bush AI, Rogers JT. Redox-active metals, oxidative stress, and Alzheimer's disease pathology. Ann NY Acad Sci 2004, 1012: 153–163
- 5 Roberson ED, Mucke L. 100 years and counting: Prospects for defeating Alzheimer's disease. Science 2006, 314: 781–784
- 6 Selkoe DJ. Alzheimer's disease: Genes, proteins, and therapy. Physiol Rev 2001, 81: 741–766
- 7 Kim W, Hecht MH. Sequence determinants of enhanced amyloidogenicity of Alzheimer Ap42 peptide relative to Aβ40. J Biol Chem 2005, 280: 35069–35076
- 8 Syme CD, Nadal RC, Rigby SE, Viles JH. Copper binding to the amyloid-β (Aβ) peptide associated with Alzheimer's disease. J Biol Chem 2004, 279: 18169–18177
- 9 Atwood CS, Moir RD, Huang X, Scarpa RC, Bacarra NM, Romano DM, Hartshorn MA et al. Dramatic aggregation of Alzheimer Aβ by Cu(II) is induced by conditions representing physiological acidosis. J Biol Chem 1998, 273: 12817–12826
- 10 Maynard CJ, Cappai R, Volitakis I, Cherny RA, White AR, Beyreuther K, Masters CL et al. Overexpression of Alzheimer's disease amyloid-β opposes the age-dependent elevations of brain copper and iron. J Biol Chem 2002, 277: 44670–44676
- 11 Opazo C, Huang X, Cherny RA, Moir RD, Roher AE, White AR, Cappai R et al. Metalloenzyme-like activity of Alzheimer's disease β-amyloid. Cu-dependent catalytic conversion of dopamine, cholesterol, and biological reducing agents to neurotoxic H2O2. J Biol Chem 2002, 277: 40302–40308
- 12 Curtain CC, Ali F, Volitakis I, Cherny RA, Norton RS, Beyreuther K, Barrow CJ et al. Alzheimer's disease amyloid-β binds copper and zinc to generate an allosterically ordered membrane-penetrating structure containing superoxide dismutase-like subunits. J Biol Chem 2001, 276: 20466–20473
- 13 White AR, Multhaup G, Maher F, Bellingham S, Camakaris J, Zheng H, Bush AI et al. The Alzheimer's disease amyloid precursor protein modulates copper-induced toxicity and oxidative stress in primary neuronal cultures. J Neurosci 1999, 19: 9170–9179
- 14 Lovell MA, Robertson JD, Teesdale WJ, Campbell JL, Markesbery WR. Copper, iron and zinc in Alzheimer's disease senile plaques. J Neurol Sci 1998, 158: 47–52
- 15 Bush AI. The metallobiology of Alzheimer's disease. Trends Neurosci 2003, 26: 207–214
- 16 Smith MA, Rottkamp CA, Nunomura A, Raina AK, Perry G. Oxidative stress in Alzheimer's disease. Biochim Biophys Acta 2000, 1502: 139–144
- 17 Huang X, Cuajungco MP, Atwood CS, Hartshorn MA, Tyndall JD, Hanson GR, Stokes KC et al., Cu(II) potentiation of Alzheimer Aβ neurotoxicity: Correlation with cell-free hydrogen peroxide production and metal reduction. J Biol Chem 1999, 274: 37111–37116
- 18 Dai XL, Sun YX, Jiang ZF. Cu(II) potentiation of Alzheimer Aβ1–40 cytotoxicity and transition on its secondary structure. Acta Biochim Biophys Sin 2006, 38: 765–772
- 19 Yoshiike Y, Tanemura K, Murayama O, Akagi T, Murayama M, Sato S, Sun X et al., New insights on how metals disrupt amyloid β-aggregation and their effects on amyloid-β cytotoxicity. J Biol Chem 2001, 276: 32293–32299
- 20 White AR, Multhaup G, Galatis D, McKinstry WJ, Parker MW, Pipkorn R, Beyreuther K et al., Contrasting, species-dependent modulation of copper-mediated neurotoxicity by the Alzheimer's disease amyloid precursor protein. J Neurosci 2002, 22: 365–376
- 21 Butterfield DA, Castegna A, Lauderback CM, Drake J. Evidence that amyloid β-peptide-induced lipid peroxidation and its sequelae in Alzheimer's disease brain contribute to neuronal death. Neurobiol Aging 2002, 23: 655–664
- 22 Grundman M. Vitamin E and Alzheimer disease: The basis for additional clinical trials. Am J Clin Nutr 2000, 7: 630S–636S
- 23 Futakawa N, Kondoh M, Ueda S, Higashimoto M, Takiguchi M, Suzuki S, Sato M. Involvement of oxidative stress in the synthesis of metallothionein induced by mitochondrial inhibitors. Biol Pharm Bull 2006, 29: 2016–2020
- 24 Jin L, Beswick RA, Yamamoto T, Palmer T, Taylor TA, Pollock JS, Pollock DM et al., Increased reactive oxygen species contributes to kidney injury in mineralocorticoid hypertensive rats. Physiol Pharmacol 2006, 57: 343–357
- 25 Zhao L, Brinton RD. Select estrogens within the complex formulation of conjugated equine estrogens (Premarin) are protective against neurodegenerative insults: Implications for a composition of estrogen therapy to promote neuronal function and prevent Alzheimer's disease. BMC Neurosci 2006, 7: 24
- 26 Li L, Zhou QX, Shi JS. Protective effects of icariin on neurons injured by cerebral ischemia/reperfusion. Chinese Med J 2005, 118: 1637–1643
- 27 Saad B, Dakwar S, Said O, Abu-Hijleh G, Al Battah F, Kmeel A, Aziazeh H. Evaluation of medicinal plant hepatotoxicity in co-cultures of hepatocytes and monocytes. Evid Based Complement Alternat Med 2006, 3: 93–98
- 28 Kicinski HG, Adamek S, Kettrup A. Trace enrichment and HPLC analysis of polycyclic aromatic hydrocarbons in environmental samples, using solid phase extraction in connection with UV/VIS diode-array and fluorescence detection. Chromatographia 1998, 28: 203–208
- 29 Smith DP, Smith DG, Curtain CC, Boas JF, Pilbrow JR, Ciccotosto GD, Lau TL et al., Copper mediated amyloid-β toxicity is associated with an intermolecular histidine bridge. J Biol Chem 2006, 281: 15145–15154
- 30 Liu YH, Huang GW, Chang H. Antioxidation of soybean isoflavone in vascular endothelial cells with oxidative damage. Zhongguo Lin Chuang Kang Fu 2006, 10: 170–172
- 31 White AR, Huang X, Jobling MF, et al. Homocysteine potentiates copper-and amyloid beta peptide-mediated toxicity in primary neuronal cultures: Possible risk factors in the Alzheimer's-type neurodegenerative pathways. J Neurochem 2001, 76: 1509–1520
- 32 Stoddart MJ, Furlong PI, Simpson A, Davies CM, Richards RG. A comparison of non-redioactive methods for assessing viability in ex vivo cultured cancellous bone: Technical note. Eur Cell Mater 2006, 12: 16–25
- 33 Finefrock AE, Bush AI, Doraiswamy PM. Current status of metals as therapeutic targets in Alzheimer's disease. J Am Geriatr Soc 2003, 51: 1143–1148
- 34 Cuajungco MP, Faget KY, Huang XD, Tanzi RE, Bush AI. Metal chelation as a potential therapy for Alzheimer's disease. Ann NY Acad Sci 2000, 920: 292–304
- 35 Maynard CJ, Bush AI, Masters CL, Cappai R, Li QX. Metals and amyloid-β in Alzheimer's disease. Int J Exp Pathol 2005, 86: 147–159
- 36 Crouch PJ, Barnham KJ, Duce JA, Blake RE, Masters CL, Trounce IA. Copper-dependent inhibition of cytochrome c oxidase by Aβ(1–42) requires reduced methionine at residue 35 of the Aβ peptide. J Neurochem 2006, 99: 226–236
- 37 Atwood CS, Scarpa RC, Huang X, Moir RD, Jones WD, Fairlie DP, Tanzi RE et al., Characterization of copper interactions with Alzheimer amyloid β peptides: Identification of an attomolar-affinity copper binding site on amyloid β1–42. J Neurochem 2000, 75: 1219–1233
- 38 Munoz FJ, Opazo C, Gil-Gomez G, Tapia G, Fernandez V, Valverde MA, Inestrosa NC. Vitamin E not 17 estradiol protects against vascular toxicity induced by amyloid wild type and the dutch amyloid variant. J Neurosci 2002, 22: 3081–3089
- 39 Naiki H, Hasegawa K, Yamaguchi I, Nakamura H, Gejyo F, Nakakuki K. Apolipoprotein E and antioxidants have different mechanisms of inhibiting Alzheimer's beta-amyloid fibril formation in vitro. Biochemistry 1998, 37: 17882–17889
- 40 Behl C, Skutella T, Lezoualc'h F, Post A, Widmann M, Newton CJ, Holsboer F. Neuroprotection against oxidative stress by estrogens: Structure-activity relationship. Mol Pharmacol 1997, 51: 535–541
- 41 Miranda S, Opazo C, Larrondo LF, Munoz FJ, Ruiz F, Leighton F, Inestrosa NC. The role of oxidative stress in the toxicity induced by amyloid β-peptide in Alzheimer's disease. Prog Neurobiol 2000, 62: 633–648
- 42 White AR, Du T, Laughton KM, Volitakis I, Sharples RA, Xilinas ME, Hoke DE et al. Degradation of the Alzheimer disease amyloid-peptide by metal-dependent up-regulation of metalloprotease activity. J Biol Chem 2006, 281: 17670–17680